Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a radiation therapy oncology group randomized trial
- 1 April 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (4), 541-549
- https://doi.org/10.1016/0360-3016(87)90069-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: An RTOG randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Sensitizers and protectors in radiotherapyCancer, 1985
- The Medical Research Council trial of misonidazole in carcinoma of the uterine cervixThe British Journal of Radiology, 1984
- The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncologyGynecologic Oncology, 1984
- Treatment of locally advanced cancer of the cervix with transperineal interstitial irradiationAmerican Journal of Clinical Oncology, 1983
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- Hyperbaric oxygen therapy for carcinoma of the cervix—Stages IIB, IIIA, IIIB and IVA: Results of a randomized study by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Misonidazole in fractionated radiotherapy: are many small fractions best?The British Journal of Radiology, 1980
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977